AstraZeneca Annual Report and 60 Form 20-F Information 2005 BOARD OF DIRECTORS AT 31 DECEMBER 2005 LOUIS SCHWEITZER 63 SIR TOM MCKILLOP 62 DAVID R BRENNAN 52 Non-Executive Chairman Executive Director and Chief Executive Executive Director Chairman of the Nomination Committee Appointed as a Director 1 January 1996.
NonRetired from the Board on 31 December 2005.
Appointed Chief Executive Officer with effect Executive Chairman of Renault SA since April Deputy Chairman of The Royal Bank of Scotland from 1 January 2006.
Chairman and Chief Executive Officer Group plc.
Non-Executive Director of BP p. l. c. Board of the Pharmaceutical Research and of Renault SA 1992-2005.
President of the Vice-President of the European Federation of Manufacturers of America PhRMA.
Chairman Management Board of Renault-Nissan BV Pharmaceutical Industries and Associations.
of the Board of the Southeastern Chapter 2002-2005.
Chief Financial Officer and Pro-Chancellor of the University of Leicester.
of the American Heart Association.
General Executive Vice-President 1988-1992 and Chairman of the British Pharma Group.
Manager of Chibret International, France President and Chief Operating Officer 1990- a subsidiary of Merck & Co. Inc. 1990-1992.
Non-Executive Director JOHN PATTERSON FRCP 58 Vice-President of Marketing, Business Planning of BNP-Paribas, Electricit fide France, Philips Executive Director, Development and Development, Astra Merck, Inc. and then Electronics NV, Veolia Environnement, Volvo Appointed as a Director 1 January 2005.
Fellow of the Royal College of Physicians.
Vice-President of Commercial Operations, Director of the British Pharma Group.
HKAN MOGREN KBE 61 Non-Executive Director of Cobham plc.
Executive Vice-President, North America, Non-Executive Deputy Chairman Non-Executive Director of Amersham plc AstraZeneca PLC 2001-2005.
Member of the Nomination Committee 2001-2004.
President of the Association Appointed as a Director 6 April 1999. of the British Pharmaceutical Industry JONATHAN SYMONDS 46 Formerly Chief Executive Officer and a 2002-2004.
Member of the Supervisory Executive Director and Director of Astra AB appointed 18 May 1988.
Board of the UK Medicines Control Agency Chief Financial Officer Vice-Chairman of Gambro AB.
Executive Vice-President, Appointed as a Director 1 October 1997. of the Board of Directors of Investor AB, Product Strategy & Licensing and Business Also has overall responsibility for Information R my Cointreau SA, Groupe Danone and Development, AstraZeneca PLC 1999-2004.
Non-Executive Director of Diageo Norsk Hydro ASA.
Director of the Marianne plc.
Member of the UK Accounting and Marcus Wallenberg Foundation.
Retired from the Board on 31 December 2005 Appointed as Chief Executive Officer with effect from 1 January 2006 61 SIR PETER BONFIELD CBE, FREng 61 JOHN BUCHANAN 62 JANE HENNEY 58 Senior Non-Executive Director Non-Executive Director Non-Executive Director Chairman of the Remuneration Committee Chairman of the Audit Committee and Member of the Audit Committee, and Member of the Nomination Committee Member of the Remuneration Committee the Nomination Committee and Appointed as a Director 1 January 1995.
Appointed as a Director 25 April 2002. the Science Committee Fellow of the Royal Academy of Engineering.
Executive Director and Group Chief Financial Appointed as a Director 24 September 2001.
Non-Executive Director of Telefonaktiebolaget Officer of BP p. l. c. 1996-2002.
Member of the Currently Senior Vice-President and Provost for LM Ericsson, Mentor Graphics Corporation, UK Accounting Standards Board 1997-2001.
Health Affairs, University of Cincinnati Medical Taiwan Semiconductor Manufacturing Senior Independent Director of BHP Billiton Center, appointed April 2003.
Prior appointments Company, Ltd. Sony Corporation, Japan and Plc.
Non-Executive Director of Vodafone include: Deputy Director, US National Cancer Actis Capital LLP.
Vice-President of The British Group Plc.
Deputy Chairman of Smith & Institute: Vice-Chancellor of Health, University of Quality Foundation.
Member of the Citigroup Nephew plc.
Kansas Medical Center: Deputy Commissioner International Advisory Board.
Member of for Operations, US Food and Drug Administration: the Sony Corporation Advisory Board.
NonMARCUS WALLENBERG 49 and Commissioner of Food and Drugs, US Executive Director, Corporate Board of the Non-Executive Director Food and Drug Administration.
Non-Executive Department for Constitutional Affairs.
Member of the Audit Committee Director of AmerisourceBergen Corporation and Appointed as a Director 6 April 1999.
Other board appointments JOE JIMENEZ 46 a Director of Astra AB appointed 18 May 1989. include The Commonwealth Fund, China Non-Executive Director Stepped down from the Audit Committee on Medical Board, OMERIS and BIO START.
Member of the Remuneration Committee 31 December 2005.
Chairman of Skandinaviska and the Nomination Committee Enskilda Banken AB.
Non-Executive ViceDAME BRIDGET OGILVIE 67 Appointed as a Director 1 July 2003.
Executive Chairman of Saab AB and Telefonaktiebolaget Non-Executive Director Vice-President of H J Heinz Company and LM Ericsson.
Non-Executive Director of Member of the Audit Committee President and Chief Executive Officer of Heinz Electrolux AB, Stora Enso Oyj and the Knut and the Science Committee Europe since 2002.
Corporate Vice-President and Alice Wallenberg Foundation.
Also then Senior Vice-President and President has responsibility for overseeing Corporate of Heinz North America 1998-2002.
Chairman of the Medicines Executive Director of Blue Nile, Inc. Non-Executive Director for Malaria Venture and the Association of Member of the Remuneration Committee Medical Research Charities.
Trustee of Cancer MICHELE HOOPER 54 and the Science Committee Research UK.
Chairman of the Trustees of the Non-Executive Director Appointed as a Director 6 April 1999.
Formerly AstraZeneca Science Teaching Trust.
Member of the Audit Committee a Director of Astra AB appointed 15 May 1995.
President Executive Director of the Knut and Alice Other officers of the Company at 31 December and Chief Executive Officer of Stadtlander Wallenberg Foundation.
Professor of Clinical 2005 included members of the Senior Executive Drug Company 1998-1999.
Corporate Immunology and Vice-Chairman of the Nobel Team, as set out on page 64, and: Vice-President and President, International Assembly, Karolinska Institutet.
Member Businesses of Caremark International Inc. of the Royal Swedish Academy of Engineering GRAEME MUSKER 1992-1998.
Non-Executive Director Sciences and the Royal Swedish Academy Group Secretary and Solicitor of PPG Industries, Inc. of Science.
Appointed as Company Secretary 6 June 1993.
